MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of October 22, 2026, MIRA trades at $0.69 with a market cap of $27.32M and a P/E ratio of -0.51. MIRA moved +1.20% today. Year to date, MIRA is -54.24%; over the trailing twelve months it is -52.98%. Its 52-week range spans $0.60 to $2.45. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MIRA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.69 |
| Market Cap | $27.32M |
| P/E Ratio | -0.51 |
| EPS | $-1.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.45 |
| 52-Week Low | $0.60 |
| Volume | 404 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.44M |
| Gross Margin | 0.00% |
1 analysts cover MIRA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.